Showing results (1931-1940 of 4,097) with videos related to
Sort By:
Pageof 410
Endocrine Journal|June 12, 2024
The role of KNDy neurons in human reproductive healthAki Oride, Haruhiko KanasakiEndocrine Journal|June 12, 2024
Therapeutic effect of selective interleukin-2-inducible tyrosine kinase inhibitor in orbital fibroblasts from patients with Graves' orbitopathyYeonjung Yoon, Hyun Young Park, Min Kyung Chae, et al.Endocrine Journal|June 5, 2024
[18F]FB(ePEG12)12-exendin-4 noninvasive imaging of insulinoma negative for insulin immunostaining on specimen from endoscopic ultrasonography-guided fine needle aspiration: a case report with review of literatureDaisuke Otani, Takaaki Murakami, Saeko Murakami, et al.Endocrine Journal|May 12, 2024
Association between COVID-19 severity and relatively high serum adiponectin levels at the time of admissionRyohei Mineo, Shiro Fukuda, Shigehito Suzuki, et al.Endocrine Journal|May 29, 2024
Prolonged impacts of sodium glucose cotransporter-2 inhibitors on metabolic dysfunction-associated steatotic liver disease in type 2 diabetes: a retrospective analysis through magnetic resonance imagingAgena Suzuki, Akinori Hayashi, Satoshi Oda, et al.Endocrine Journal|January 7, 2026
Dysregulation of miR-642a-5p is involved in the regulation of pancreatic β-cell function via Mef2dMeixiao Liu, Yan Yue, Linqi Zhang, et al.Endocrine Journal|November 19, 2025
Chromosomal and hormonal factors involved in human sexual dimorphismMaki Fukami, Kohji Okamura, Shoko Sasaki, et al.Endocrine Journal|January 8, 2025
Hypertriglyceridemia and younger age are associated with effectiveness of growth hormone therapy on hepatic steatosisTomomi Taguchi, Shiori Ito, Rei Fujishima, et al.Endocrine Journal|February 2, 2025
Characteristics of patients with Graves' disease who developed drug resistance and required surgeryYusuke Shibata, Ako Oiwa, Hiroki Tanaka, et al.Endocrine Journal|February 2, 2025
Association between serum thyroglobulin levels and glycemic control in patients with thyroid cancer after radioiodine therapyYuji Hataya, Yuko Fujishima, Kanta Fujimoto, et al.Pageof 410